2026-10-15T10:23:16Z https://data.mendeley.com/oai

oai:data.mendeley.com/dypcbvk6ky.2 2026-09-18T13:49:47Z

He, Yuanxiong Week 4 Response to Abrocitinib Predicts Week 12 Remission and Correlates with Glycolytic Pathway Modulation in Moderate to Severe Atopic Dermatitis Mendeley Data Supplementary materials for the JAAD manuscript "Week‑4 Response to Abrocitinib Predicts Week‑12 Remission and Correlates with Glycolytic Pathway Modulation in Moderate‑to‑Severe Atopic Dermatitis" include two supplementary Figures, four supplementary Tables, supplementary Methods, and supplementary Figure Legends. Supplementary Figure 1. Proteomic profiles of lesions after treatment. Supplementary Figure 2. Changes of glucose metabolism pathway and identification of response-related proteins in ERs. Supplementary Table 1. Univariate and multivariable binary logistic regression analyses exploring the association between week 4 early response and clinical outcome in patients with atopic dermatitis. Supplementary Table 2. Comparison of baseline demographic and clinical characteristics between the protein sequencing group and non-protein sequencing group of AD patients. Supplementary Table 3. Comparison of baseline characteristics between early response and early non-response groups after propensity score matching. Supplementary Table 4. Treatment-related DEPs and DEGs in skin lesions of atopic dermatitis. Tablet Fig Deng, Sisi Gao, Cuie Luo, Siqi Li, Ran Wang, Huan Chen, Qiquan Song, Zhiqiang Dataset doi:10.17632/dypcbvk6ky.2 oai:data.mendeley.com/dypcbvk6ky.2 Creative Commons Attribution 4.0 International http://creativecommons.org/licenses/by/4.0 https://data.mendeley.com/datasets/dypcbvk6ky 2026-09-18T13:49:47Z